Some people who develop COVID-19 experience persistence of symptoms. Here, we aimed to understand the factors associated with the severity and persistence of these symptoms in adults 50 years and older living in the community who had COVID-19. Using information provided by 23,757 participants fr...
COVID-19 has severely impacted global healthcare services. Malta has only one acute state hospital, Mater Dei Hospital (MDH), and at the time of writing is the most vaccinated country in Europe. Malta thus provides an ideal setting to assess the imp
with infection detected by seropositivity) from the definitions used in the above studies (generally, the reduction in the incidence of infection among a vaccinated and/or boosted intervention arm relative to a reference arm of unvaccinated or less-vaccinated individuals, with infection detected by vo...
WEDNESDAY, Sept. 27, 2023 (HealthDay News) -- Just 23% of American adults say they 'definitely' will get the new COVID-19 vaccine, while another 23% say they will 'probably' get it, according to a new poll, which also finds interest in the shot falls along ...
(Cf. Sect. 9.3.1.3) AstraZeneca had indicated that, according to a 32,000-person trial—which had included volunteers from the United States, Chile and Peru—its vaccine had shown 79% efficacy against Covid-19 with any symptoms. AstraZeneca had also claimed that the Oxford-AstraZeneca Co...
This cross-sectional study estimates ever and current experiences of lasting COVID-19 symptoms among children and adolescents by sociodemographic characteristics. Pediatrics Adolescent Medicine Full Text | pdf link PDF Mortality Trends Among Early Adults in the United States, 1999-2023 JAMA Network ...
Pragmatic trial evidence from high-income countries among a largely vaccinated population remains an important evidence gap, as does an understanding of whether ivermectin can reduce persistent symptoms or improve function in the longer term. We aimed to determine whether ivermectin speeds recovery and ...
Fifteen of them (62.5%) required additional therapy: anti-IL-1 or anti-IL-6 in 45.8% of cases (anakinra n = 4 and tocilizumab n = 7), methotrexate in 4 cases and IVIg in 3 cases. The outcomes have been generally favorable with a rapid regression of symptoms. IL-6 levels were ...
Lopez Bernal, J. et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.BMJ373, n1088 (2021). ...
observed in adults and children, respectively.10The hamster model can simulate serious COVID-19 diseases. Syrian hamsters show mild to severe symptoms 1–2 days after nasal infection,89,90and progressive weight loss and dyspnea. The NHP model can reflect mild-to-moderate SARS-CoV-2 infection an...